We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $8.21B
1-Year Est. Return 28.81%
This Fund
S&P 500
This Quarter Est. Return
+2.6%
1 Year Est. Return
+28.81%
3 Year Est. Return
+92.54%
5 Year Est. Return
+114.67%
10 Year Est. Return
+429.8%
AUM
$3.34B
AUM Growth
+$209M
Cap. Flow
+$157M
Cap. Flow %
4.72%
Top 10 Hldgs %
12.01%
Holding
1,564
New
189
Increased
576
Reduced
529
Closed
163

Sector Composition

Rank Sector Weight
1 Energy 11.94%
2 Healthcare 10.62%
3 Industrials 9.8%
4 Technology 9.43%
5 Financials 9.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AB icon
376
AllianceBernstein
AB
$3.43B
$2.03M 0.06%
81,204
-27,354
-25% -$641K
IWF icon
377
iShares Russell 1000 Growth ETF
IWF
$120B
$2.01M 0.06%
93,020
+17,976
+24% +$386K
AZN icon
378
AstraZeneca
AZN
$266B
$2.01M 0.06%
30,994
-4,460
-13% -$288K
CBSH icon
379
Commerce Bancshares
CBSH
$8.55B
$2.01M 0.06%
77,795
+45,942
+144% +$1.14M
FTA icon
380
First Trust Large Cap Value AlphaDEX Fund
FTA
$1.39B
$1.98M 0.06%
48,095
+2,372
+5% +$94.3K
SH icon
381
ProShares Short S&P500
SH
$913M
$1.98M 0.06%
10,030
+757
+8% +$153K
ICF icon
382
iShares Select U.S. REIT ETF
ICF
$2.1B
$1.97M 0.06%
47,854
+3,878
+9% +$154K
PPL
383
PPL Corp
PPL
$26.8B
$1.96M 0.06%
63,638
+3,711
+6% +$108K
NFLX icon
384
Netflix
NFLX
$305B
$1.95M 0.06%
388,570
-673,190
-63% -$3.86M
VMW
385
DELISTED
VMware, Inc
VMW
$1.95M 0.06%
18,034
+3,790
+27% +$372K
LNT icon
386
Alliant Energy
LNT
$18.3B
$1.95M 0.06%
68,510
SBSI icon
387
Southside Bancshares
SBSI
$960M
$1.95M 0.06%
73,539
+1,780
+2% +$42.8K
FXI icon
388
iShares China Large-Cap ETF
FXI
$4.37B
$1.94M 0.06%
54,346
-3,712
-6% -$130K
CEQP
389
DELISTED
Crestwood Equity Partners LP
CEQP
$1.94M 0.06%
14,007
+299
+2% +$40.2K
FLG
390
Flagstar Bank National Association
FLG
$5.94B
$1.94M 0.06%
40,188
+17,216
+75% +$837K
SEE
391
DELISTED
Sealed Air
SEE
$1.93M 0.06%
+58,838
New +$1.92M
FXH icon
392
First Trust Health Care AlphaDEX Fund
FXH
$1.04B
$1.93M 0.06%
37,829
-1,459
-4% -$74.3K
FFIV icon
393
F5
FFIV
$22.1B
$1.92M 0.06%
18,010
-70
-0.4% -$7.41K
TJX icon
394
TJX Companies
TJX
$176B
$1.92M 0.06%
63,152
+39,724
+170% +$1.2M
GNW icon
395
Genworth Financial
GNW
$3.81B
$1.89M 0.06%
106,828
-7,399
-6% -$119K
UI icon
396
Ubiquiti
UI
$32.3B
$1.88M 0.06%
41,415
-2,651
-6% -$124K
BRE
397
DELISTED
BRE PROPERTIES INC CL A
BRE
$1.88M 0.06%
+29,975
New +$1.8M
FVD icon
398
First Trust Value Line Dividend Fund
FVD
$8.33B
$1.86M 0.06%
84,919
-2,436
-3% -$51.8K
MOAT icon
399
VanEck Morningstar Wide Moat ETF
MOAT
$11.8B
$1.86M 0.06%
63,307
-991
-2% -$28.4K
ETP
400
DELISTED
Energy Transfer Partners L.p.
ETP
$1.85M 0.06%
34,491
+6,959
+25% +$377K

Similar funds

Oppenheimer & Co's Q1 2014 Portfolio in Review

As of Q1 2014, Oppenheimer & Co held 1,564 positions worth $3.34B, up 6.7% from $3.13B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Oppenheimer & Co deployed $157M of net new capital in Q1 2014, opening 189 new positions and adding to 576 existing holdings. Its largest new stake was Vanguard Morningstar Total Stock Market ETF: 169,083 shares worth $16.5M.

By sector, the portfolio is most concentrated in Energy at 12% of assets, down from 12% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Vanguard Dividend Appreciation ETF, an estimated $7.79M trimmed.

  • Oppenheimer & Co's largest Q1 2014 buy was Vanguard Morningstar Total Stock Market ETF: 169,083 shares worth $16.5M.
  • Oppenheimer & Co added most to Monsanto Co in Q1 2014, an estimated $30M increase.
  • Oppenheimer & Co's biggest Q1 2014 reduction was Vanguard Dividend Appreciation ETF, cutting an estimated $7.79M.
  • Oppenheimer & Co fully exited TetraLogic Pharmaceuticals Corporation in Q1 2014, selling an estimated $10.2M.
  • Oppenheimer & Co's ten largest holdings make up 12% of its $3.34B portfolio in Q1 2014.
  • Oppenheimer & Co opened 189 new positions and closed 163 in Q1 2014.
  • Oppenheimer & Co's portfolio value rose 6.7% quarter-over-quarter to $3.34B.

Based on Oppenheimer & Co's 13F filing for Q1 2014, filed 9 May 2014.